Sittner & Nelson’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Hold
8,200
0.42% 56
2025
Q4
$1.25M Sell
8,200
-130
-2% -$15.8K 0.44% 50
2025
Q3
$925K Hold
8,330
0.34% 54
2025
Q2
$924K Sell
8,330
-200
-2% -$21.3K 0.37% 53
2025
Q1
$956K Hold
8,530
0.41% 44
2024
Q4
$788K Buy
8,530
+9
+0.1% +$810 0.34% 51
2024
Q3
$714K Buy
8,521
+2,425
+40% +$185K 0.32% 53
2024
Q2
$418K Sell
6,096
-746
-11% -$49.8K 0.21% 74
2024
Q1
$501K Buy
6,842
+716
+12% +$55.1K 0.25% 65
2023
Q4
$496K Sell
6,126
-319
-5% -$24.8K 0.27% 64
2023
Q3
$483K Buy
6,445
+333
+5% +$25.6K 0.28% 59
2023
Q2
$471K Sell
6,112
-207
-3% -$16.5K 0.26% 63
2023
Q1
$524K Sell
6,319
-2,184
-26% -$181K 0.3% 59
2022
Q4
$730K Sell
8,503
-46
-0.5% -$3.64K 0.45% 46
2022
Q3
$527K Buy
8,549
+907
+12% +$57.2K 0.35% 53
2022
Q2
$472K Buy
7,642
+1,879
+33% +$116K 0.31% 58
2022
Q1
$343K Buy
5,763
+301
+6% +$19.2K 0.2% 79
2021
Q4
$397K Buy
5,462
+10
+0.2% +$689 0.23% 71
2021
Q3
$381K Buy
5,452
+950
+21% +$66.7K 0.25% 70
2021
Q2
$310K Buy
4,502
+300
+7% +$20K 0.22% 69
2021
Q1
$272K Sell
4,202
-898
-18% -$57.9K 0.2% 72
2020
Q4
$297K Buy
+5,100
New +$308K 0.27% 69

Other funds holding GILD

Sittner & Nelson's GILD Position: Q1 2026 in Review

Sittner & Nelson held its Gilead Sciences (GILD) position steady in Q1 2026 at 8,200 shares worth $1.14M. The position accounts for 0.42% of the portfolio, ranked #56.

Sittner & Nelson first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.25M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Sittner & Nelson held 8,200 shares of Gilead Sciences worth $1.14M as of Q1 2026.
  • Sittner & Nelson left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.42% of Sittner & Nelson's portfolio in Q1 2026, its #56 holding.
  • Sittner & Nelson first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
  • Sittner & Nelson's Gilead Sciences position peaked at $1.25M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sittner & Nelson's 13F filing for Q1 2026, filed 12 May 2026.